• Founded in 1999
  • Employees: 90

Description :

Cellectis develops innovative cancer products based on engineered T cells armed with a Chimeric Antigen Receptor (CAR) to target liquid and solid tumor

Headquarters :

8 rue de la Croix Jarry, paris

Related Posts

We use cookies to give you the best experience. If you click on accept, we also use tracking cookies for analytics and advertising purposes. Check our privacy policy for more details. By accepting, you support our independent media and its’ freely accessible content. You may withdraw your consent at any time.